Search Results
Results found for "Gregory Tall"
- From Ox Liver to AI: How the History of Pharmacology Shapes Its Future
Fast-forward a few thousand years, and we’re talking beta receptors, receptor theory, and AI-generated All of it connected. All of it is essential. Dr.
- 📰 GPCR Weekly News, September 11 to 17, 2023
If you have registered, please submit poster abstracts through this form and the short talk selections Targeted and Immuno-oncology Sosei Heptares Adds World-leading Expertise to its Scientific Advisory Board Call
- 📰 GPCR Weekly News, August 28 to September 3, 2023
You can submit your poster abstracts using this form and short talks will be selected from abstracts. Global Healthcare Conference CEO Raymond Stevens to Speak at STAT Future Summit on Obesity Therapeutics Call
- Fly casting with ligand sliding and orientational selection supporting complex formation of a GPCR..
All molecular components (bosentan, hETB, membrane, and solvent) were represented with an all-atom model bosentan fluctuating randomly in solution is captured using a tip region of the flexible N-terminal tail Bosentan then slides occasionally from the tip to the root of the N-terminal tail (ligand–sliding). The bosentan-captured conformations by the tip-region and root-region of the N-terminal tail correspond
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
Hiring Won’t Save Your GPCR Drug Discovery Program When a drug discovery program stalls, the default Ambiguous Decision Gates: Molecules advance or stall based on vibes, not criteria.
- From Snapshots to Predictions: Why Mechanism of Action Matters
And here’s the danger: if you can’t tell how a drug is working, every downstream decision—SAR, lead When Two Mechanisms Look the Same Some of the most difficult calls in pharmacology happen when two different Without the right model, it’s like staring at identical twins—you can’t tell them apart until you see That could be: An orthosteric partial agonist , or An allosteric partial agonist The raw data won’t tell When data alone are ambiguous, models tell you which parameters to control, which conditions to vary,
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Randy Hall's study: GPR37L1's role in shaping cortical astrocytes during development Dr. Research Collaboration Addex Therapeutics To Release Half-Year 2023 Financial Results And Host Conference Call
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
Expand your computational toolkit ➤ Call for Papers: GPCRs: Signal Transduction, Volume II Building on Don’t Fall Behind—Access the Edge You Need 👉 Access all the news and upcoming events ➤ 👉 Already a
- 📰 GPCR Weekly News, February 20 to 26, 2023
All-Atom Molecular Dynamics Simulations Indicated the Involvement of a Conserved Polar Signaling Channel Slow-rising and fast-falling dopaminergic dynamics jointly adjust negative prediction error in the ventral understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia Call
- 📰 GPCR Weekly News, January 15 to 21, 2024
The course covers basic pharmacology in four weekly segments and is open to all with a free site membership with advanced gastroenteropancreatic neuroendocrine tumors Neurocrine Biosciences Announces Conference Call rescue option for asthma GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- Episode 87 of Dr. GPCR Podcast is available now!
Listen to her talk about her work and her transition to PI in Belfast.
- Trainees, this is for you...
Give a talk or present a poster at the Dr. GPCR Summit 2022.
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
Kenakin talked about the specific allosteric properties orthosteric drugs cannot offer. control over receptor output, these GPCR pharmacology insights determine whether a series advances or stalls
- Join Us Now!
This is a great opportunity for us to come together and talk GPCRs. Do you want to be part of it? Our Summit is FREE for all Ecosystem site members, which is also free!
- From One to Many: How a GPCR Curiosity Became a Field-Wide Toolkit
In fact, it all began with a phone call (from Bruce Merrifield, no less) encouraging Sakmar to work on pilot data came together, rotation student Ilana Kotliar joined and pushed the project to scale across all
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Find speaker details on the Live Talks page and mark your calendar HERE. Progresses Its GLP-1 Receptor Agonist PF-06954522 into a Phase 1 Trial Andrew Hopkins Inducted into RSC BMCS Hall
- When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission
"When you talk to patients that have an unmet need, you learn things that no one is thinking about in
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
The cross-talk between growth factor receptors and GPCRs is an intriguing area of study. of specific phosphorylation events provide a deeper understanding of the molecular basis for cross-talk
- Mapping Motion: Intermediate States, Deorphanization & Discovery
Learn the fundamentals of ligand activity, mechanism of action, and GPCR discovery strategy—all at your GPCR Symposia – On-demand talks from GPCR trailblazers Watch anytime. Learn from the best.
- Diversification of PAR signaling through receptor crosstalk
physiological and pathological relevance of these interactions, since this additional level of molecular cross-talk
- From Lab Logic to Leadership: How Scientific Thinking Holds Back Biotech Operations
Stalled progress. Clarity doesn’t precede action; it follows it. 2️⃣ “Eliminate error at all costs” Labs are built around Trying to eliminate all risk leads to overengineering and stagnation . 👉 Instead of shipping early and The discipline to align a team without all the answers. Real leadership often means choosing without all the answers.
- New structural perspectives in G protein-coupled receptor-mediated Src family kinase activation
Sandra Berndt talk about new structural perspectives in GPCR-mediated Src family kinase activation.
- Automated micro-plate-based methods for quantifying GPCR activation
Joe Clayton from BioTek Instruments talk about automated micro-plate-based methods for quantifying #GPCR
- 📰 GPCR Weekly News, May 15 to 21, 2023
We express our gratitude to the speakers for their excellent talks. If you are interested in giving a talk, contact us at Hello@DrGPCR.com, and if you would like to present
- From Venice to Virtual Molecules: Alessandro Nicoli’s Unexpected Journey into Computational Chemistry
Falling for Computational Chemistry Alessandro’s master’s thesis brought him face to face with his “second Let’s embrace the challenge to study all of them.”
- The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology
development, the field has remained too focused on ion channels like NAV1.8 , despite these targets falling
- Time is your enemy, GPCRs are your friend
Come attend this month's virtual café talk to see the awesome work of Dr.
- How to Avoid the Most Common Gaps in Your Biotech Pitch
If your pitch doesn’t immediately tell them who it’s for, why it matters, and what makes it different They’re trying to understand the opportunity. 👉 Opening with mechanisms forces the listener to do all If your listener doesn’t know what to do next or who should be involved, the conversation stalls. ✅ A If your pitch keeps stalling, stop editing your deck. Start refining your message.
- GPR110, a receptor for synaptamide, expressed in osteoclasts negatively regulates osteoclastogenesis
GPR110 belongs to adhesion GPCR and was the functional receptor of N-docosahexaenoyl ethanolamine (also called
- Dr. Simone Promel
Join us for another virtual cafe talk to hear about the amazing work that Dr.


















